Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Short-Term Treatment Effects of a Substance Use Disorder Therapy Involving Traditional Amazonian Medicine.

Berlowitz I, Walt H, Ghasarian C, Mendive F, Martin-Soelch C.

J Psychoactive Drugs. 2019 Sep-Oct;51(4):323-334. doi: 10.1080/02791072.2019.1607956. Epub 2019 May 1.

PMID:
31043116
2.

Conceptions and practices of an integrative treatment for substance use disorders involving Amazonian medicine: traditional healers' perspectives.

Berlowitz I, Ghasarian C, Walt H, Mendive F, Alvarado V, Martin-Soelch C.

Braz J Psychiatry. 2017 Dec 18;40(2):200-209. doi: 10.1590/1516-4446-2016-2117. Print 2018 Apr-June.

3.

Short-term effectiveness of inpatient cancer rehabilitation: A longitudinal controlled cohort study.

Ture M, Angst F, Aeschlimann A, Renner C, Schnyder U, Zerkiebel N, Perseus J, Barth J, Bredell M, Soelch CM, Walt H, Jenewein J.

J Cancer. 2017 Jul 1;8(10):1717-1725. doi: 10.7150/jca.19564. eCollection 2017.

4.

Lipid nanoemulsions and liposomes improve photodynamic treatment efficacy and tolerance in CAL-33 tumor bearing nude mice.

Hinger D, Gräfe S, Navarro F, Spingler B, Pandiarajan D, Walt H, Couffin AC, Maake C.

J Nanobiotechnology. 2016 Oct 3;14(1):71.

5.

Use of inpatient rehabilitation for cancer patients in Switzerland: who undergoes cancer rehabilitation?

Ture M, Barth J, Angst F, Aeschlimann A, Schnyder U, Zerkiebel N, Perseus J, Renner C, Imesch P, Fuchs B, Huber GF, Walt H, Martin-Soelch C, Jenewein J.

Swiss Med Wkly. 2015 Dec 4;145:w14214. doi: 10.4414/smw.2015.14214. eCollection 2015.

6.

Engineered Inorganic/Organic-Core/Shell Magnetic FexOy Nanoparticles with Oleic Acid and/or Oleylamine As Capping Agents.

Harris RA, van der Walt H, Shumbula PM.

Curr Pharm Des. 2015;21(37):5369-88. Review.

PMID:
26377658
7.

Analysis of the interaction of surfactants oleic acid and oleylamine with iron oxide nanoparticles through molecular mechanics modeling.

Harris RA, Shumbula PM, van der Walt H.

Langmuir. 2015 Apr 7;31(13):3934-43. doi: 10.1021/acs.langmuir.5b00671. Epub 2015 Mar 26.

PMID:
25768034
8.

Veterinary photodynamic therapy: a review.

Buchholz J, Walt H.

Photodiagnosis Photodyn Ther. 2013 Dec;10(4):342-7. doi: 10.1016/j.pdpdt.2013.05.009. Epub 2013 Jul 1. Review.

PMID:
24284083
9.

Gold nanoparticle based Tuberculosis immunochromatographic assay: the quantitative ESE Quanti analysis of the intensity of test and control lines.

Mdluli P, Tetyana P, Sosibo N, van der Walt H, Mlambo M, Skepu A, Tshikhudo R.

Biosens Bioelectron. 2014 Apr 15;54:1-6. doi: 10.1016/j.bios.2013.10.019. Epub 2013 Oct 30.

PMID:
24220512
10.

Effects of hypericin and a chlorin based photosensitizer alone or in combination in squamous cell carcinoma cells in the dark.

Besic Gyenge E, Forny P, Lüscher D, Laass A, Walt H, Maake C.

Photodiagnosis Photodyn Ther. 2012 Dec;9(4):321-31. doi: 10.1016/j.pdpdt.2012.03.006. Epub 2012 Apr 16.

PMID:
23200013
11.

Photodynamic mechanisms induced by a combination of hypericin and a chlorin based-photosensitizer in head and neck squamous cell carcinoma cells.

Gyenge EB, Lüscher D, Forny P, Antoniol M, Geisberger G, Walt H, Patzke G, Maake C.

Photochem Photobiol. 2013 Jan-Feb;89(1):150-62. doi: 10.1111/j.1751-1097.2012.01217.x. Epub 2012 Sep 13.

PMID:
22882495
12.

Gastro-intestinal stromal tumours (GISTs) - the Pretoria experience and a literature review.

Hartley RJ, Becker JH, Van der Walt H, Luvhengo T.

S Afr J Surg. 2011 Aug 31;49(3):128-31. Review.

PMID:
21933497
13.

Uptake and fate of surface modified silica nanoparticles in head and neck squamous cell carcinoma.

Besic Gyenge E, Darphin X, Wirth A, Pieles U, Walt H, Bredell M, Maake C.

J Nanobiotechnology. 2011 Aug 11;9:32. doi: 10.1186/1477-3155-9-32.

14.

Cellular and molecular effects of the liposomal mTHPC derivative Foslipos in prostate carcinoma cells in vitro.

Gyenge EB, Hiestand S, Graefe S, Walt H, Maake C.

Photodiagnosis Photodyn Ther. 2011 Jun;8(2):86-96. doi: 10.1016/j.pdpdt.2011.02.001.

15.

The application and challenges of clinical PD-PDT in the head and neck region: a short review.

Bredell MG, Besic E, Maake C, Walt H.

J Photochem Photobiol B. 2010 Dec 2;101(3):185-90. doi: 10.1016/j.jphotobiol.2010.07.002. Epub 2010 Jul 16. Review.

PMID:
20732819
16.

(Ferrocenyl-thio-phospho-nato-κS)(triphenyl-phosphane-κP)gold(I) dichloro-methane monosolvate.

van der Walt H, Muller A, Staples RJ, Van Zyl WE.

Acta Crystallogr Sect E Struct Rep Online. 2010 Oct 9;66(Pt 11):m1364-5. doi: 10.1107/S1600536810039255.

17.

Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light.

Schneider-Yin X, Kurmanaviciene A, Roth M, Roos M, Fedier A, Minder EI, Walt H.

Photodiagnosis Photodyn Ther. 2009 Mar;6(1):12-8. doi: 10.1016/j.pdpdt.2009.02.001. Epub 2009 Mar 16.

PMID:
19447367
18.
19.

Personality and academic performance of three cohorts of veterinary students in South Africa.

van der Walt HS, Pickworth G.

J Vet Med Educ. 2007 Summer;34(3):356-65.

PMID:
17673797
20.

Novel flexible light diffuser and irradiation properties for photodynamic therapy.

Selm B, Rothmaier M, Camenzind M, Khan T, Walt H.

J Biomed Opt. 2007 May-Jun;12(3):034024.

21.

Early apoptotic responses in transgenic mouse mammary carcinoma for photodynamic therapy.

Walt H, Nap M, Dorward AM, Leers MP, Tennent BJ, Varga Z, Stallmach T, Björklund V, Beamer WG.

Photodiagnosis Photodyn Ther. 2006 Dec;3(4):227-33. doi: 10.1016/j.pdpdt.2006.07.002. Epub 2006 Sep 15.

PMID:
25046987
22.

Performance of a contact textile-based light diffuser for photodynamic therapy.

Khan T, Unternährer M, Buchholz J, Kaser-Hotz B, Selm B, Rothmaier M, Walt H.

Photodiagnosis Photodyn Ther. 2006 Mar;3(1):51-60. doi: 10.1016/S1572-1000(05)00182-1. Epub 2006 Feb 8.

PMID:
25049027
23.

Changes in vascularity and blood volume as a result of photodynamic therapy can be assessed with power Doppler ultrasonography.

Ohlerth S, Laluhová D, Buchholz J, Roos M, Walt H, Kaser-Hotz B.

Lasers Surg Med. 2006 Mar;38(3):229-34.

PMID:
16392148
24.
25.

Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.

Buchholz J, Kaser-Hotz B, Khan T, Rohrer Bley C, Melzer K, Schwendener RA, Roos M, Walt H.

Clin Cancer Res. 2005 Oct 15;11(20):7538-44.

26.

Yorkshire Laser Centre mobile photodynamic therapy unit: For service to district general hospitals (Keyvan Moghissi & Kate Dixon).

Walt H.

Photodiagnosis Photodyn Ther. 2005 Sep;2(3):174. doi: 10.1016/S1572-1000(05)00108-0. No abstract available.

PMID:
25048767
27.

Preoperative esophageal manometry does not predict postoperative dysphagia following anti-reflux surgery.

Cole SJ, van den Bogaerde JB, van der Walt H.

Dis Esophagus. 2005;18(1):51-6.

PMID:
15773843
28.

Changing professional practice in tuberculosis care: an educational intervention.

Dick J, Lewin S, Rose E, Zwarenstein M, Walt H.

J Adv Nurs. 2004 Dec;48(5):434-42.

PMID:
15533081
29.

Endovascular treatment of intractable epistaxis--results of a 4-year local audit.

Duncan IC, Fourie PA, le Grange CE, van der Walt HA.

S Afr Med J. 2004 May;94(5):373-8.

PMID:
15211958
30.

Ciliary motility in bovine oviducts for sensing rapid non-genomic reactions upon exposure to progesterone.

Wessel T, Schuchter U, Walt H.

Horm Metab Res. 2004 Mar;36(3):136-41.

PMID:
15057665
31.
32.

Health systems research training enhances workplace research skills: a qualitative evaluation.

Adams J, Schaffer A, Lewin S, Zwarenstein M, van der Walt H.

J Contin Educ Health Prof. 2003 Fall;23(4):210-20.

PMID:
14730791
33.

Association between promyelocyte protein and small ubiquitin-like modifier protein and the progression of cervical neoplasia.

Szendefi M, Walt H, Krasieva TB, Caduff R, Osann KE, LaMorte VJ.

Obstet Gynecol. 2003 Dec;102(6):1269-77.

PMID:
14662214
34.

Role of p53 and ATM in photodynamic therapy-induced apoptosis.

Heinzelmann-Schwarz V, Fedier A, Hornung R, Walt H, Haller U, Fink D.

Lasers Surg Med. 2003;33(3):182-9.

PMID:
12949948
35.

Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient.

Zimmermann A, Walt H, Haller U, Baas P, Klein SD.

Cancer Chemother Pharmacol. 2003 Feb;51(2):147-54. Epub 2002 Dec 6.

PMID:
12647016
36.
37.

Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells.

Schwarz VA, Hornung R, Fedier A, Fehr MK, Walt H, Haller U, Fink D.

Br J Cancer. 2002 Apr 8;86(7):1130-5.

38.

Hypercalcemic-type of small cell carcinoma of the ovary: characterization of a new tumor line.

Walt H, Hornung R, Fink D, Dobler-Girdziunaite D, Stallmach T, Spycher MA, Maly F, Haller U, Bürki N.

Anticancer Res. 2001 Sep-Oct;21(5):3253-9.

PMID:
11848480
39.

Stigma and HIV/AIDS care. Perspective from South Africa.

van der Walt H, Mailula S, de la Porte A.

IAPAC Mon. 2001 Nov;7(11):315, 318. No abstract available.

PMID:
11799950
40.

Skin protection for photosensitized patients.

Schwarz VA, Klein SD, Hornung R, Knochenmuss R, Wyss P, Fink D, Haller U, Walt H.

Lasers Surg Med. 2001;29(3):252-9.

PMID:
11573228
41.

Primary ciliary dyskinesia with situs inversus totalis, hydrocephalus internus and cardiac malformations in a dog.

Reichler IM, Hoerauf A, Guscetti F, Gardelle O, Stoffel MH, Jentsch B, Walt H, Arnold S.

J Small Anim Pract. 2001 Jul;42(7):345-8.

PMID:
11480901
42.

Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer.

Wyss P, Schwarz V, Dobler-Girdziunaite D, Hornung R, Walt H, Degen A, Fehr M.

Int J Cancer. 2001 Sep 1;93(5):720-4.

43.

Resistance to topoisomerase poisons due to loss of DNA mismatch repair.

Fedier A, Schwarz VA, Walt H, Carpini RD, Haller U, Fink D.

Int J Cancer. 2001 Aug 15;93(4):571-6.

44.

Overexpression of Bcl-2 enhances sensitivity of L929 cells to a lipophilic cationic photosensitiser.

Klein SD, Walt H, Rocha S, Ghafourifar P, Pruschy M, Winterhalter KH, Richter C.

Cell Death Differ. 2001 Feb;8(2):204-6. No abstract available.

PMID:
11313723
45.

Synergistic toxicity of delta-aminolaevulinic acid-induced protoporphyrin IX used for photodiagnosis and hypericum extract, a herbal antidepressant.

Ladner DP, Klein SD, Steiner RA, Walt H.

Br J Dermatol. 2001 Apr;144(4):916-8. No abstract available.

PMID:
11298571
46.

Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid.

Ladner DP, Steiner RA, Allemann J, Haller U, Walt H.

Br J Cancer. 2001 Jan 5;84(1):33-7.

47.

PEG-m-THPC-mediated photodynamic effects on normal rat tissues.

Hornung R, Fehr MK, Walt H, Wyss P, Berns MW, Tadir Y.

Photochem Photobiol. 2000 Nov;72(5):696-700.

PMID:
11107857
48.

Comparative genomic hybridization of fine needle aspirates from breast carcinomas.

Bürki NG, Caduff R, Walt H, Moll C, Pejovic T, Haller U, Ward DC.

Int J Cancer. 2000 Nov 15;88(4):607-13.

49.

Primary ciliary dyskinesia: a genome-wide linkage analysis reveals extensive locus heterogeneity.

Blouin JL, Meeks M, Radhakrishna U, Sainsbury A, Gehring C, Saïl GD, Bartoloni L, Dombi V, O'Rawe A, Walne A, Chung E, Afzelius BA, Armengot M, Jorissen M, Schidlow DV, van Maldergem L, Walt H, Gardiner RM, Probst D, Guerne PA, Delozier-Blanchet CD, Antonarakis SE.

Eur J Hum Genet. 2000 Feb;8(2):109-18.

50.

Photodynamic therapy for the hypercalcemic type of the small cell carcinoma of the ovary in a mouse xenograft model.

Hornung R, Fink D, Dobler-Girdziunaite D, Stallmach T, Haller U, Walt H.

Gynecol Oncol. 1999 Dec;75(3):447-52.

PMID:
10600305

Supplemental Content

Support Center